SULPERAZON Side Effects

6409687-5 | Anaphylactic Shock, Hypersensitivity
on Oct 12, 2009 Female patient from CHINA , 63 years of age, was diagnosed with infection (What is infection?) and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, hypersensitivity. Sulperazon dosage: 2 G, 2x/day. During the same period patient was treated with LIPOVENOES (View Lipovenoes Review and Lipovenoes Label ), AMINO ACIDS (View Amino Acids Review and Amino Acids Label ).

6393848-8 | Hypersensitivity
Patient was taking Sulperazon (View Usage). Patient had the following side effects: hypersensitivity on Sep 25, 2009 from CHINA Additional patient health information: Female patient , 63 years of age, was diagnosed with infection (What is infection?) and. Sulperazon dosage: 2 G, 2x/day. During the same period patient was treated with LIPOVENOES (View Lipovenoes Review and Lipovenoes Label ), AMINO ACIDS (View Amino Acids Review and Amino Acids Label ).

6373612-6 | Shock
Adverse event was reported on Sep 14, 2009 by a Female patient taking Sulperazon (View Usage) (Dosage: 1 G, 2x/day) . Location: JAPAN , 79 years of age, After Sulperazon was administered, patient had the following side effects: shock.

6345539-7 | Swollen Tongue
on Aug 28, 2009 Female patient from JAPAN , 71 years of age, was diagnosed with pyrexia and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: swollen tongue. Sulperazon dosage: .


6341511-1 | Erythema Multiforme
on Aug 24, 2009 Female patient from THAILAND , 66 years of age, was diagnosed with endocarditis (What is endocarditis?) and was treated with Sulperazon (View Usage). Patient had the following side effects: erythema multiforme. Sulperazon dosage: 2 G, 1x/day. During the same period patient was treated with COLISTIN (75 Mg, 1x/day) (View Colistin Review and Colistin Label ), HUMULIN 70/30 (View Humulin 70/30 Review and Humulin 70/30 Label ), VITAMIN B 1 6 12 (View Vitamin B 1-6-12 Review and Vitamin B 1-6-12 Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), FBC (View Fbc Review and Fbc Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), PREVACID (View Prevacid Review and Prevacid Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6334956-7 | Swollen Tongue
Patient was taking Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: swollen tongue on Aug 19, 2009 from JAPAN Additional patient health information: Female patient , 71 years of age, . Sulperazon dosage: .

6322215-8 | Shock
Adverse event was reported on Aug 12, 2009 by a Female patient taking Sulperazon (View Usage) (Dosage: 1 G, 2x/day) . Location: JAPAN , 79 years of age, Patient experienced the following unwanted or unexpected effects: shock.

6304360-6 | Stevens-johnson Syndrome
on Jul 30, 2009 Female patient from THAILAND , 66 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Sulperazon (View Usage). Patient had the following side effects: stevens-johnson syndrome. Sulperazon dosage: 2 G, 1x/day. During the same period patient was treated with COLISTIN (75 Mg, 1x/day) (View Colistin Review and Colistin Label ), HUMULIN 70/30 (View Humulin 70/30 Review and Humulin 70/30 Label ), VITAMIN B 1 6 12 (View Vitamin B 1-6-12 Review and Vitamin B 1-6-12 Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), FBC (View Fbc Review and Fbc Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), PREVACID (View Prevacid Review and Prevacid Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6303417-3 | Interstitial Lung Disease
on Jul 29, 2009 Female patient from JAPAN , 62 years of age, was diagnosed with cholangitis and was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: interstitial lung disease. Sulperazon dosage: 1 G, 2x/day. During the same period patient was treated with BIAPENEM (View Biapenem Review and Biapenem Label ), GARENOXACIN MESILATE (View Garenoxacin Mesilate Review and Garenoxacin Mesilate Label ). Patient was hospitalized.

6299231-8 | Activated Partial Thromboplastin Time Prolonged, Haemoglobin Decreased, Prothrombin Time Prolonged, Upper Gastrointestinal Haemorrhage
Patient was taking Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, haemoglobin decreased, prothrombin time prolonged, upper gastrointestinal haemorrhage on Jul 25, 2009 from CHINA Additional patient health information: Female patient , 84 years of age, was diagnosed with lung infection and. Sulperazon dosage: 3 G, 2x/day.

6267296-5 | Musculoskeletal Disorder, Necrosis
Adverse event was reported on Jul 02, 2009 by a Female patient taking Sulperazon (View Usage) (Dosage: 2 G, 2x/day) was diagnosed with pseudomonas infection and. Location: CHINA , 47 years of age, Patient had the following side effects: musculoskeletal disorder, necrosis. During the same period patient was treated with TAZOCIN (View Tazocin Review and Tazocin Label ), ZYVOX (View Zyvox Review and Zyvox Label ), CIPROFLOXACIN HYDROCHLORIDE (View Ciprofloxacin Hydrochloride Review and Ciprofloxacin Hydrochloride Label ).

6263628-2 | Amnesia, Anaphylactic Shock
on Jun 29, 2009 Female patient from JAPAN , 43 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: amnesia, anaphylactic shock. Sulperazon dosage: . During the same period patient was treated with KAKKON TO (Unk) (View Kakkon-to Review and Kakkon-to Label ), GEFANIL (Unk) (View Gefanil Review and Gefanil Label ), LIGHTGEN T (Unk) (View Lightgen T Review and Lightgen T Label ), BISOLVON (Unk) (View Bisolvon Review and Bisolvon Label ), INTEBAN (Unk) (View Inteban Review and Inteban Label ), ZITHROMAX (Unk) (View Zithromax Review and Zithromax Label ), PL GRAN. (Unk) (View Pl Gran. Review and Pl Gran. Label ).

6262155-6 | Haemorrhage Intracranial
on Jun 29, 2009 Female patient from CHINA , child 12 years of age, was diagnosed with infection (What is infection?) and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhage intracranial. Sulperazon dosage: Unk. During the same period patient was treated with VITAMIN K (View Vitamin K Review and Vitamin K Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ).

6240761-2 | Amnesia, Anaphylactic Shock
Patient was taking Sulperazon (View Usage). Patient had the following side effects: amnesia, anaphylactic shock on Jun 11, 2009 from JAPAN Additional patient health information: Female patient , 43 years of age, . Sulperazon dosage: .

6236440-8 | Anaphylactic Shock, Disseminated Intravascular Coagulation
Adverse event was reported on Jun 05, 2009 by a Female patient taking Sulperazon (View Usage) (Dosage: 1 G, 2x/day) was diagnosed with pneumonia (What is pneumonia?), peritonitis and. Location: JAPAN , 59 years of age, After Sulperazon was administered, patient had the following side effects: anaphylactic shock, disseminated intravascular coagulation. During the same period patient was treated with LACTEC (Unk) (View Lactec Review and Lactec Label ), GASTER (Unk) (View Gaster Review and Gaster Label ), REMINARON (Unk) (View Reminaron Review and Reminaron Label ), PRIMPERAN (Unk) (View Primperan Review and Primperan Label ), SOSEGON (Unk) (View Sosegon Review and Sosegon Label ).

6217122-5 | Coma Hepatic, Hepatorenal Syndrome
on May 25, 2009 Female patient from CHINA , 38 years of age, was diagnosed with lung infection and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: coma hepatic, hepatorenal syndrome. Sulperazon dosage: 2 G, 2x/day. During the same period patient was treated with CEFOTAXIME SODIUM (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), ESSENTIALE (View Essentiale Review and Essentiale Label ), VITAMIN K (Unk) (View Vitamin K Review and Vitamin K Label ), DIURETICS (Unk) (View Diuretics Review and Diuretics Label ).

6204423-X | Interstitial Lung Disease
on May 15, 2009 Female patient from JAPAN , 70 years of age, was treated with Sulperazon (View Usage). Patient had the following side effects: interstitial lung disease. Sulperazon dosage: Unk G, Unk.

6059492-7 | White Blood Cell Count Decreased
Patient was taking Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: white blood cell count decreased on Jan 20, 2009 from CHINA Additional patient health information: Male patient , 80 years of age, was diagnosed with bronchitis (What is bronchitis?) and. Sulperazon dosage: 4 G, 2x/day. During the same period patient was treated with MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), DIPROPHYLLINE (View Diprophylline Review and Diprophylline Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

5955803-9 | Alcohol Intolerance, Blood Pressure Decreased, Shock
Adverse event was reported on Nov 05, 2008 by a Male patient taking Sulperazon (View Usage) (Dosage: ) was diagnosed with enterocolitis bacterial and. Location: JAPAN , weighting 127.9 lb, Patient experienced the following unwanted or unexpected effects: alcohol intolerance, blood pressure decreased, shock. During the same period patient was treated with ESPO (View Espo Review and Espo Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), TANKARU (View Tankaru Review and Tankaru Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), POLAPREZINC (View Polaprezinc Review and Polaprezinc Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

5945374-5 | Hepatitis Fulminant
on Oct 28, 2008 Female patient from JAPAN , weighting 163.1 lb, was diagnosed with pyrexia, upper respiratory tract inflammation, liver disorder and was treated with Sulperazon (View Usage). Patient had the following side effects: hepatitis fulminant. Sulperazon dosage: Daily Dose:2gram-freq:daily. During the same period patient was treated with PONSTEL (Daily Dose:250mg-freq:qd) (View Ponstel Review and Ponstel Label ), CIPROXAN (Daily Dose:200mg-freq:daily) (View Ciproxan Review and Ciproxan Label ), TRANSAMIN (View Transamin Review and Transamin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), CELESTAMINE TAB (View Celestamine Tab Review and Celestamine Tab Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), URSO 250 (Daily Dose:600mg-freq:daily) (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

5938229-3 | Platelet Count Decreased
on Oct 20, 2008 Male patient from JAPAN , 69 years of age, was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: platelet count decreased. Sulperazon dosage: .

5938223-2 | Alcohol Intolerance
Patient was taking Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol intolerance on Oct 20, 2008 from JAPAN Additional patient health information: Male patient , 63 years of age, . Sulperazon dosage: .

5931891-0 | Urine Output Decreased
Adverse event was reported on Oct 15, 2008 by a Male patient taking Sulperazon (View Usage) (Dosage: ) was diagnosed with meningitis (What is meningitis?) and. Location: PHILIPPINES , weighting 127.9 lb, Patient had the following side effects: urine output decreased. During the same period patient was treated with AMOXICILLIN + CLAVULANATE POTASSIUM (View Amoxicillin + Clavulanate Potassium Review and Amoxicillin + Clavulanate Potassium Label ).

5923003-4 | Hepatitis Fulminant
on Oct 07, 2008 Female patient from JAPAN , weighting 164.0 lb, was diagnosed with pyrexia, liver disorder and was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: hepatitis fulminant. Sulperazon dosage: Daily Dose:2gram-freq:daily. During the same period patient was treated with PONTAL (Daily Dose:250mg-freq:qd) (View Pontal Review and Pontal Label ), CIPROXAN (Daily Dose:200mg-freq:daily) (View Ciproxan Review and Ciproxan Label ), TRANSAMIN (View Transamin Review and Transamin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), CELESTAMINE TAB (View Celestamine Tab Review and Celestamine Tab Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), URSO 250 (Daily Dose:600mg-freq:daily) (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

5902042-3 | Platelet Count Decreased
on Sep 17, 2008 Male patient from JAPAN , weighting 127.9 lb, was diagnosed with jaundice cholestatic, infection (What is infection?) and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Sulperazon dosage: Daily Dose:2gram. During the same period patient was treated with VEEN D (View Veen D Review and Veen D Label ), GLUCOSE W/ELECTROLYTES (View Glucose W/electrolytes Review and Glucose W/electrolytes Label ), SOLITA T 3G (View Solita-t 3g Review and Solita-t 3g Label ). Patient was hospitalized.

5880095-9 | Hypersensitivity, Pulmonary Fibrosis
Patient was taking Sulperazon (View Usage). Patient had the following side effects: hypersensitivity, pulmonary fibrosis (What is pulmonary fibrosis?) on Sep 02, 2008 from JAPAN Additional patient health information: Female patient , 41 years of age, was diagnosed with fibrinolysis and. Sulperazon dosage: . Patient was hospitalized.

5851985-8 | Hepatitis Fulminant
Adverse event was reported on Aug 08, 2008 by a Female patient taking Sulperazon (View Usage) (Dosage: ) was diagnosed with pyrexia, liver disorder and. Location: JAPAN , 19 years of age, After Sulperazon was administered, patient had the following side effects: hepatitis fulminant. During the same period patient was treated with PONSTEL (View Ponstel Review and Ponstel Label ), TRANSAMIN (View Transamin Review and Transamin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), CELESTAMINE TAB (View Celestamine Tab Review and Celestamine Tab Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ). Patient was hospitalized.

5842564-7 | Shock
on Jul 31, 2008 Female patient from JAPAN , 80 years of age, was diagnosed with cholangitis acute and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: shock. Sulperazon dosage: .

5840917-4 | Hepatitis Fulminant
on Jul 30, 2008 Female patient from JAPAN , 19 years of age, was diagnosed with pyrexia and was treated with Sulperazon (View Usage). Patient had the following side effects: hepatitis fulminant. Sulperazon dosage: . During the same period patient was treated with PONSTEL (View Ponstel Review and Ponstel Label ), TRANSAMIN (View Transamin Review and Transamin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), CELESTAMINE TAB (View Celestamine Tab Review and Celestamine Tab Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ). Patient was hospitalized.

5827944-8 | Hypoprothrombinaemia
Patient was taking Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: hypoprothrombinaemia on Jul 18, 2008 from JAPAN Additional patient health information: Female patient , 90 years of age, weighting 92.59 lb, was diagnosed with biliary tract infection and. Sulperazon dosage: . During the same period patient was treated with LACTEC (View Lactec Review and Lactec Label ), ADONA (View Adona Review and Adona Label ), TRANSAMIN (View Transamin Review and Transamin Label ), FOY (View Foy Review and Foy Label ), PARIET (View Pariet Review and Pariet Label ), FERROMIA (View Ferromia Review and Ferromia Label ).

5826285-2 | Renal Failure Acute
Adverse event was reported on Jul 17, 2008 by a Female patient taking Sulperazon (View Usage) (Dosage: ) was diagnosed with pneumonia aspiration and. Location: JAPAN , weighting 91.71 lb, Patient experienced the following unwanted or unexpected effects: renal failure acute. During the same period patient was treated with FAMOTIDINE (View Famotidine Review and Famotidine Label ), CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ), ATARAX (View Atarax Review and Atarax Label ), ADONAMIN C (View Adonamin-c Review and Adonamin-c Label ), LASIX (View Lasix Review and Lasix Label ), DOPAMINE HYDROCHLORIDE (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ). Patient was hospitalized.

5823688-7 | Red Blood Cell Count Decreased, White Blood Cell Count Decreased
on Jul 14, 2008 Female patient from CHINA , 64 years of age, was diagnosed with infection (What is infection?) and was treated with Sulperazon (View Usage). Patient had the following side effects: red blood cell count decreased, white blood cell count decreased. Sulperazon dosage: .

5815388-4 | Thrombocytopenia
on Jul 08, 2008 Female patient from JAPAN , weighting 121.3 lb, was diagnosed with sepsis (What is sepsis?), infection prophylaxis and was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: thrombocytopenia. Sulperazon dosage: Daily Dose:2gram. During the same period patient was treated with CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), MEROPEN (View Meropen Review and Meropen Label ), ZANTAC (View Zantac Review and Zantac Label ), FASUDIL HYDROCHLORIDE (View Fasudil Hydrochloride Review and Fasudil Hydrochloride Label ). Patient was hospitalized.

5806458-5 | Platelet Count Decreased
Patient was taking Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased on Jun 30, 2008 from JAPAN Additional patient health information: Male patient , weighting 128.5 lb, was diagnosed with jaundice cholestatic and. Sulperazon dosage: Daily Dose:2gram-freq:frequency: Bid. During the same period patient was treated with VEEN D (View Veen D Review and Veen D Label ), MAGNES CHLORIDE/MALTOSE/POTAS CHLORIDE/POTAS PHOS MONOBAS/SOD ACET/SOD (View Magnes Chloride/maltose/potas Chloride/potas Phos Monobas/sod Acet/sod Review and Magnes Chloride/maltose/potas Chloride/potas Phos Monobas/sod Acet/sod Label ), SOLITA T 3G (View Solita-t 3g Review and Solita-t 3g Label ). Patient was hospitalized.

5806451-2 | Nephritis Interstitial
Adverse event was reported on Jun 30, 2008 by a Female patient taking Sulperazon (View Usage) (Dosage: ) was diagnosed with cholangitis and. Location: JAPAN , 64 years of age, Patient had the following side effects: nephritis interstitial. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ).

5804990-1 | Lung Injury
on Jun 30, 2008 Female patient from JAPAN , 69 years of age, was diagnosed with infective spondylitis and was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: lung injury. Sulperazon dosage: Daily Dose:2gram. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATARAX (View Atarax Review and Atarax Label ), MEXITIL (View Mexitil Review and Mexitil Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), SOLANAX (View Solanax Review and Solanax Label ), TAKEPRON (View Takepron Review and Takepron Label ), URSO 250 (View Urso 250 Review and Urso 250 Label ).

5802131-8 | Renal Failure Acute
on Jun 26, 2008 Female patient from JAPAN , 93 years of age, was diagnosed with pneumonia aspiration and was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Sulperazon dosage: .

5802056-8 | Disseminated Intravascular Coagulation, Thrombocytopenia
Patient was taking Sulperazon (View Usage). Patient had the following side effects: disseminated intravascular coagulation, thrombocytopenia on Jun 25, 2008 from JAPAN Additional patient health information: Female patient , weighting 121.3 lb, was diagnosed with sepsis (What is sepsis?), infection prophylaxis and. Sulperazon dosage: Daily Dose:2gram. During the same period patient was treated with CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), MEROPEN (View Meropen Review and Meropen Label ), ZANTAC (View Zantac Review and Zantac Label ), FASUDIL HYDROCHLORIDE (View Fasudil Hydrochloride Review and Fasudil Hydrochloride Label ). Patient was hospitalized.

5781095-X | Thrombocytopenia
Adverse event was reported on Jun 10, 2008 by a Female patient taking Sulperazon (View Usage) (Dosage: Daily Dose:2gram) was diagnosed with sepsis (What is sepsis?), endocarditis (What is endocarditis?), infection prophylaxis and. Location: JAPAN , 56 years of age, After Sulperazon was administered, patient had the following side effects: thrombocytopenia. During the same period patient was treated with CEFAZOLIN SODIUM (Daily Dose:2gram) (View Cefazolin Sodium Review and Cefazolin Sodium Label ), MEROPEN (Daily Dose:1.5gram) (View Meropen Review and Meropen Label ), ZANTAC (View Zantac Review and Zantac Label ). Patient was hospitalized.

5754766-9 | Platelet Count Decreased
on May 23, 2008 Male patient from JAPAN , 39 years of age, was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Sulperazon dosage: Daily Dose:2gram. Patient was hospitalized.

5751163-7 | Visual Disturbance
on May 19, 2008 Female patient from JAPAN , 77 years of age, was treated with Sulperazon (View Usage). Patient had the following side effects: visual disturbance. Sulperazon dosage: .

5748493-1 | Anaphylactic Shock
Patient was taking Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: anaphylactic shock on May 15, 2008 from JAPAN Additional patient health information: Male patient , weighting 121.3 lb, was diagnosed with cholangitis, bile duct cancer and. Sulperazon dosage: . During the same period patient was treated with GEMZAR (View Gemzar Review and Gemzar Label ), DECADRON (View Decadron Review and Decadron Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), SODIUM CHLORIDE INJ (View Sodium Chloride Inj Review and Sodium Chloride Inj Label ). Patient was hospitalized.

5746929-3 | Gastrointestinal Haemorrhage
Adverse event was reported on May 12, 2008 by a Male patient taking Sulperazon (View Usage) (Dosage: ) . Location: , 67 years of age, Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage.

5739452-3 | Gastrointestinal Haemorrhage
on May 06, 2008 Male patient from CHINA , 67 years of age, was treated with Sulperazon (View Usage). Patient had the following side effects: gastrointestinal haemorrhage. Sulperazon dosage: .

5713412-0 | Neutrophil Count Decreased, White Blood Cell Count Decreased
on Apr 10, 2008 Female patient from JAPAN , 98 years of age, was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: neutrophil count decreased, white blood cell count decreased. Sulperazon dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), HOKUNALIN (View Hokunalin Review and Hokunalin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

5708537-X | Bleeding Time Prolonged
Patient was taking Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: bleeding time prolonged on Apr 07, 2008 from MALAYSIA Additional patient health information: Male patient , 33 years of age, was diagnosed with acinetobacter infection and. Sulperazon dosage: Daily Dose:6gram-freq:daily.

5707664-0 | Coagulopathy, Gastrointestinal Haemorrhage, Haematemesis
Adverse event was reported on Apr 07, 2008 by a Female patient taking Sulperazon (View Usage) (Dosage: Daily Dose:2gram-freq:daily) was diagnosed with sepsis (What is sepsis?) and. Location: MALAYSIA , 54 years of age, Patient had the following side effects: coagulopathy, gastrointestinal haemorrhage, haematemesis.

5622373-4 | Anaphylactic Shock
on Jan 31, 2008 Female patient from JAPAN , 70 years of age, was treated with Sulperazon (View Usage). After Sulperazon was administered, patient had the following side effects: anaphylactic shock. Sulperazon dosage: .

5611606-6 | Pancreatitis
on Jan 22, 2008 Female patient from JAPAN , child 7 years of age, was treated with Sulperazon (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis. Sulperazon dosage: . During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), GASTER (View Gaster Review and Gaster Label ), MIRACLID (View Miraclid Review and Miraclid Label ), CARBENIN (View Carbenin Review and Carbenin Label ).

5564030-9 | Chest Pain
Patient was taking Sulperazon (View Usage). Patient had the following side effects: chest pain (What is chest pain?) on Dec 06, 2007 from JAPAN Additional patient health information: Male patient , 70 years of age, . Sulperazon dosage: .